Your browser doesn't support javascript.
loading
[Drug clinical comprehensive evaluation of tetrandrine in the treatment of pneumoconiosis].
Zhang, Z L; He, N; Xu, X H; Men, P; Guan, L; Li, D H; Zhai, S D.
Afiliação
  • Zhang ZL; Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China.
  • He N; Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China.
  • Xu XH; Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China.
  • Men P; Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China.
  • Guan L; Department of Occupational Disease, Peking University Third Hospital, Beijing 100191, China.
  • Li DH; National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
  • Zhai SD; Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China.
Article em Zh | MEDLINE | ID: mdl-37006149

Texto completo: 1 Base de dados: MEDLINE Medicinas Tradicionais: Medicinas_tradicionales_de_asia / Medicina_china Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas Assunto principal: Pneumoconiose / Medicamentos de Ervas Chinesas / Benzilisoquinolinas Tipo de estudo: Clinical_trials / Guideline / Health_technology_assessment / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: Zh Revista: Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Medicinas Tradicionais: Medicinas_tradicionales_de_asia / Medicina_china Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas Assunto principal: Pneumoconiose / Medicamentos de Ervas Chinesas / Benzilisoquinolinas Tipo de estudo: Clinical_trials / Guideline / Health_technology_assessment / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: Zh Revista: Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China